vs
Side-by-side financial comparison of Incyte (INCY) and StoneX Group Inc. (SNEX). Click either name above to swap in a different company.
Incyte is the larger business by last-quarter revenue ($1.3B vs $1.2B, roughly 1.1× StoneX Group Inc.). Incyte runs the higher net margin — 23.8% vs 11.6%, a 12.3% gap on every dollar of revenue. On growth, StoneX Group Inc. posted the faster year-over-year revenue change (81.0% vs 20.9%). Over the past eight quarters, StoneX Group Inc.'s revenue compounded faster (53.5% CAGR vs 10.4%).
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
StoneX Group Inc. is an American financial services company. The company operates in six areas: commercial hedging, global payments, securities, physical commodities, foreign exchange and clearing and execution services (CES).
INCY vs SNEX — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.2B |
| Net Profit | $303.3M | $139.0M |
| Gross Margin | — | — |
| Operating Margin | 23.7% | 15.4% |
| Net Margin | 23.8% | 11.6% |
| Revenue YoY | 20.9% | 81.0% |
| Net Profit YoY | 91.7% | 63.3% |
| EPS (diluted) | $1.47 | $2.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.4B | $32.7B | ||
| Q2 25 | $1.2B | $851.2M | ||
| Q1 25 | $1.1B | $820.4M | ||
| Q4 24 | $1.2B | $663.1M | ||
| Q3 24 | $1.1B | $31.1B | ||
| Q2 24 | $1.0B | $571.8M |
| Q1 26 | $303.3M | — | ||
| Q4 25 | $299.3M | $139.0M | ||
| Q3 25 | $424.2M | $85.7M | ||
| Q2 25 | $405.0M | $63.4M | ||
| Q1 25 | $158.2M | $71.7M | ||
| Q4 24 | $201.2M | $85.1M | ||
| Q3 24 | $106.5M | $76.7M | ||
| Q2 24 | $-444.6M | $61.9M |
| Q1 26 | — | — | ||
| Q4 25 | 92.0% | — | ||
| Q3 25 | 92.8% | 3.7% | ||
| Q2 25 | 93.5% | — | ||
| Q1 25 | 93.0% | — | ||
| Q4 24 | 92.5% | — | ||
| Q3 24 | 92.4% | 3.0% | ||
| Q2 24 | 92.7% | — |
| Q1 26 | 23.7% | — | ||
| Q4 25 | 22.3% | 15.4% | ||
| Q3 25 | 32.5% | 0.3% | ||
| Q2 25 | 43.6% | -1.3% | ||
| Q1 25 | 19.5% | -1.0% | ||
| Q4 24 | 25.6% | -3.2% | ||
| Q3 24 | 12.8% | -0.0% | ||
| Q2 24 | -45.8% | -4.7% |
| Q1 26 | 23.8% | — | ||
| Q4 25 | 19.9% | 11.6% | ||
| Q3 25 | 31.1% | 0.3% | ||
| Q2 25 | 33.3% | 7.4% | ||
| Q1 25 | 15.0% | 8.7% | ||
| Q4 24 | 17.1% | 12.8% | ||
| Q3 24 | 9.4% | 0.2% | ||
| Q2 24 | -42.6% | 10.8% |
| Q1 26 | $1.47 | — | ||
| Q4 25 | $1.46 | $2.50 | ||
| Q3 25 | $2.11 | $0.72 | ||
| Q2 25 | $2.04 | $1.22 | ||
| Q1 25 | $0.80 | $1.41 | ||
| Q4 24 | $0.90 | $1.69 | ||
| Q3 24 | $0.54 | $2.32 | ||
| Q2 24 | $-2.04 | $1.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.6B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $5.6B | $2.5B |
| Total Assets | $7.3B | $47.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.1B | $1.6B | ||
| Q3 25 | $2.5B | $1.6B | ||
| Q2 25 | $2.0B | $1.3B | ||
| Q1 25 | $1.9B | $1.3B | ||
| Q4 24 | $1.7B | $1.4B | ||
| Q3 24 | $1.3B | $1.3B | ||
| Q2 24 | $987.3M | $1.2B |
| Q1 26 | $5.6B | — | ||
| Q4 25 | $5.2B | $2.5B | ||
| Q3 25 | $4.7B | $2.4B | ||
| Q2 25 | $4.2B | $2.0B | ||
| Q1 25 | $3.7B | $1.9B | ||
| Q4 24 | $3.4B | $1.8B | ||
| Q3 24 | $3.2B | $1.7B | ||
| Q2 24 | $3.0B | $1.6B |
| Q1 26 | $7.3B | — | ||
| Q4 25 | $7.0B | $47.8B | ||
| Q3 25 | $6.3B | $45.3B | ||
| Q2 25 | $5.8B | $34.3B | ||
| Q1 25 | $5.7B | $31.3B | ||
| Q4 24 | $5.4B | $29.6B | ||
| Q3 24 | $5.0B | $27.5B | ||
| Q2 24 | $4.7B | $25.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-1.3B |
| Free Cash FlowOCF − Capex | — | $-1.3B |
| FCF MarginFCF / Revenue | — | -106.4% |
| Capex IntensityCapex / Revenue | — | 1.3% |
| Cash ConversionOCF / Net Profit | — | -9.08× |
| TTM Free Cash FlowTrailing 4 quarters | — | $3.5B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $543.3M | $-1.3B | ||
| Q3 25 | $559.4M | $3.5B | ||
| Q2 25 | $44.7M | $1.5B | ||
| Q1 25 | $266.1M | $-154.5M | ||
| Q4 24 | $381.2M | $-477.8M | ||
| Q3 24 | $310.9M | $192.6M | ||
| Q2 24 | $-575.6M | $-622.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-1.3B | ||
| Q3 25 | — | $3.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $-169.8M | ||
| Q4 24 | — | $-491.4M | ||
| Q3 24 | — | $175.9M | ||
| Q2 24 | — | $-640.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | -106.4% | ||
| Q3 25 | — | 10.7% | ||
| Q2 25 | — | 173.3% | ||
| Q1 25 | — | -20.7% | ||
| Q4 24 | — | -74.1% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | -112.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.3% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 1.9% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 3.2% |
| Q1 26 | — | — | ||
| Q4 25 | 1.82× | -9.08× | ||
| Q3 25 | 1.32× | 41.18× | ||
| Q2 25 | 0.11× | 23.52× | ||
| Q1 25 | 1.68× | -2.15× | ||
| Q4 24 | 1.89× | -5.61× | ||
| Q3 24 | 2.92× | 2.51× | ||
| Q2 24 | — | -10.05× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
